T cells, particularly CD8+ T cells, are required for therapeutic effects of RT, as demonstrated by a study wherein deletion of CD8+ T cells largely abolished RT-induced growth suppression of primary melanoma [134]. This evidence concerns the gene CD8A and melanoma.